<DOC>
	<DOCNO>NCT00260962</DOCNO>
	<brief_summary>The purpose study evaluate efficacy anti-psychotic medication , Olanzapine , achieve desire weight gain patient identify Anorexia Nervosa , either restrict binge/purge subtype . The study also evaluate possible beneficial effect Olanzapine reduce severity obsessive and/or anxiety symptom associate disorder .</brief_summary>
	<brief_title>Olanzapine Treatment Patients With Anorexia Nervosa</brief_title>
	<detailed_description>The purpose study evaluate efficacy anti-psychotic medication , Olanzapine , achieve desire weight gain patient identify Anorexia Nervosa , either restrict binge/purge subtype . The study also evaluate possible beneficial effect Olanzapine reduce severity obsessive and/or anxiety symptom associate disorder .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>meet DSM IV criterion Anorexia Nervosa either restrict binge/purge subtype patient actively self destructive and/or suicidal patient whose medical status seriously compromise patient whose eat disorder superimpose major psychiatric disorder schizophrenia , major affective disorder , dissociative disorder active substance abuse disorder .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Pilot Project ,</keyword>
	<keyword>Clinical Trial ,</keyword>
	<keyword>Treatment Outcome ,</keyword>
	<keyword>Psychopharmacology</keyword>
</DOC>